(Total Views: 425)
Posted On: 10/13/2025 3:22:59 AM
Post# of 157994
I just hope eIND, CSP are not affected. Shareholders should not be overriding and going around CytoDyn, practically demanding BTD status of the FDA. Lalezari implied that kind of action would probably be deleterious to their progress.
(4)
(0)
